- Home
- MVF vs FDMT Comparison
MVF vs FDMT Comparison
Compare MVF & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MVF | FDMT |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.3M | 466.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MVF | FDMT |
|---|---|---|
| Price | $7.04 | $9.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $34.13 |
| AVG Volume (30 Days) | 162.8K | ★ 750.3K |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,000.00 |
| Revenue This Year | N/A | $21,227.03 |
| Revenue Next Year | N/A | $161.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 605.88 |
| 52 Week Low | $5.85 | $2.24 |
| 52 Week High | $7.19 | $12.34 |
Technical Indicators
Market Signals| Indicator | MVF | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 57.64 |
| Support Level | $6.99 | $8.75 |
| Resistance Level | $7.07 | $9.39 |
| Average True Range (ATR) | 0.06 | 0.64 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 66.92 | 76.67 |
Price Performance
Historical ComparisonAbout MVF Blackrock MuniVest Fund Inc.
Blackrock Munivest Fund Inc is an investment management firm. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company invests in various sectors such as Health; Transportation; Utilities; Education; Tobacco; Housing and others.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.